KF
IRWD icon

Krilogy Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Krilogy Financial’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Sell
26,348
-6,846
-21% -$26.4K ﹤0.01% 1003
2026
Q1 		$144K Buy
33,194
+2,971
+10% +$12.2K ﹤0.01% 921
2025
Q4 		$157K Buy
30,223
+15
+0% +$39 0.01% 893
2025
Q3 		$62.2K Buy
+30,208
New +$31.3K ﹤0.01% 850

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Krilogy Financial's IRWD Position: Q2 2026 in Review

Krilogy Financial reduced its Ironwood Pharmaceuticals (IRWD) stake by 21% in Q2 2026, selling an estimated $26.4K and leaving 26,348 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

Krilogy Financial first reported a position in IRWD in Q3 2025 and has held it in 4 quarters since. The position peaked at $157K in Q4 2025. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Krilogy Financial held 26,348 shares of Ironwood Pharmaceuticals worth $111K as of Q2 2026.
  • Krilogy Financial sold 6,846 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $26.4K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Krilogy Financial's portfolio in Q2 2026, its #1003 holding.
  • Krilogy Financial first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Krilogy Financial's Ironwood Pharmaceuticals position peaked at $157K in Q4 2025.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.